Back

Global longitudinal strain evolution after cancer treatment in breast cancer females

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology and mechanisms in chronic heart failure (2) Cardiotoxicity of Drugs and Other Therapies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nourchene Amdouni Moussi

Military Hospital of Tunis, Tunis (Tunisia)

3 More presentations in this session

Presentation thumbnail
EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Miss J. Zhang (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Impact of the 2022 ESC/ERS guidelines on diagnosing pulmonary hypertension in heart failure with reduced ejection fraction patients undergoing elective right heart catheterization
Mr F. Sawczak (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Sex differences in functional capacity and haemodynamic features in patients with dilated cardiomyopathy (DCM) with similar clinical characteristics
Doctor F. Giardino (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology and mechanisms in chronic heart failure (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Normal left ventricular ejection fraction and impaired longitudinal strain: is this significant cardiotoxicity? - what do the guidelines say?
thumbnail
Congress Session
Guidelines in Practice: cardiac imaging in cancer and the 2022 ESC Guidelines on Cardio-Oncology
thumbnail
Congress Presentation
Ejection fraction vs. global longitudinal strain for cancer treatment surveillance

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources